Report on Cardiovascular Health and Diseases in China 2022:an Updated Summary

作     者：The Writing Committee of the Report on Cardiovascular Health and Diseases in China The Writing Committee of the Report on Cardiovascular Health and Diseases in China

作者机构：The Writing Committee of the Report on Cardiovascular Health and Diseases in China 

出 版 物：《生物医学与环境科学:英文版》 (Biomedical and Environmental Sciences)

年 卷 期：2023年第36卷第8期

页      面：669-701页

核心收录：

学科分类：0830[工学-环境科学与工程（可授工学、理学、农学学位）] 1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Cardiovascular disease Epidemiology Health influencing factor Risk factor Prevalence Mortality Community-based prevention and control Rehabilitation Basic research Medical device development 

摘      要：In the past 30 years,the accessibility and quality index of medical care have made remarkable progress in China,ranking the first among middle-income *** cardiovascular technologies are at or near the world s leading level,and significant progress has been achieved in China solving the problem of“treatment difficultyof cardiovascular diseases(CVD).However,due to the prevalence of unhealthy lifestyles among Chinese residents,a huge population with CVD risk factors,accelerated population aging,and other reasons,the incidence and mortality rate of CVD are still increasing,and the turning point of the decline in disease burden has not appeared yet in *** terms of proportions of disease mortality among urban and rural residents,CVD still ranks the *** 2020,CVD accounted for 48.00%and 45.86%of the causes of death in rural and urban areas,respectively;two out of every five deaths were due to *** is estimated that the number of current CVD patients in China is around 330 million,including 13 million stroke,11.39 million coronary heart disease,8.9 million heart failure,5 million pulmonary heart disease,4.87 million atrial fibrillation,2.5 million rheumatic heart disease,2 million congenital heart disease,45.3 million peripheral artery disease,and 245 million hypertension *** has entered a new stage of transformation from high-speed development to high-quality development,and the prevention and control of CVD in China should also shift from previous emphasis on scale growth to strategies focusing more on strategic and key technological development in order to curb the trend of increasing incidence and mortality rates of CVD.